Journal on oncology (ISSN 2692-563X)

Journal on oncology
ISSN 2692-563X
Impact Factor: 1.3

Journal on oncology publishes relevant and up-to-date open access journals in the fields of experimental and clinical oncology research.

How important is early Disease Detection through Regular Systematic Examinations in People older than 65 Years: An Example of Two Cases

Ana Miljković

Role of Androgen Receptor in Prostate Cancer: A Brief Update

Mohammed Akhtar; Khaled A Murshed*; Noheir M Taha; Hussam Telfah; Issam Al Bozom

Why Choose Us?

Open Access

Open access publications are freely and permanently available online to anyone with an internet connection.

Quick Review Process

Journal on oncology (ISSN 2692-563X) follows a quick peer-review process and a rapid publication of the articles.

Our Guidelines

They are guidelines that should be followed by authors, reviewers and editors to maintain the journal integrity.

Latest Articles

Relationship Between Two Key Non-Coding RNAS in Breast Cancer: HOTAIR and miR-331-3p

Research Article Open Access

Breast Cancer (BC) is the most common cancer type among women; although the cancer is not limited to females, it is rarely seen in men (only 0.5-1% of breast cancers are found in men) [1]. In Iran, based on the GLOBALCAN 2020 report, breast cancer was recognized as the most abundant type

PDF
HTML

RAS and PI3K Driver Mutations in Metastatic Colorectal Cancer: A Cohort Study of 60 Patients

Research Article Open Access

Colorectal Cancer (CRC) is the third most common malignancy worldwide, with metastatic disease (MCRC) accounting for a significant proportion of cases [1]. The management of mCRC has shifted toward precision oncology, driven by the identification of predictive biomarkers [2]. Among these, RAS gene

PDF
HTML

Influence of Reproductive Factors on Breast Cancer Outcomes in Premenopausal Women

Research Article Open Access

The incidence of breast cancer in young, premenopausal women has been steadily increasing since the 2000s. Surveillance, Epidemiology, and End Results (SEER) program data from 2019-2022 demonstrated an annual breast cancer incidence rate of 24-25 per 100,000 in women under 40. The rates vary across

PDF
HTML

Androgen Receptor as a Prognostic and Predictive Factor for Response to Trastuzumab Among Female Patients with Invasive HER2-Positive Breast Cancer

Research Article Open Access

Breast cancers overexpressing Human Epidermal growth factor Receptor-2 (HER2) have relatively poor outcome. Androgen receptor in breast cancer was studied and showed different prognostic data among the different molecular breast cancer subtypes.

PDF
HTML

Cardiac Safety of Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: A One-Year Prospective Echocardiographic Study

Research Article Open Access

Trastuzumab Deruxtecan (T-DXd) is a novel antibody–drug conjugate with proven efficacy in HER2-positive metastatic breast cancer. While its safety profile is generally favorable, data on cardiotoxicity remains limited.

PDF
HTML

About Our Journal

The Journal publishes original research articles related to oncology, our journal covers articles related to all types on cancers and make sure that the published articles should be available online for the researchers and medical practisers.

We are maintaining a highest level of reviews whether it is peer to peer or editorial review process. Our most important factor in publishing the journals is the quality or impact on the researchers. We try to put as many as reviewers such that the manuscript submitted should be reviewed from many different angels and editors comments are always forward back to the submitter such that can rework into it where it is necessary. Our goal is to publish articles which can really help the researchers.